Theranos failure could have broad impact
February 12, 2016 at 13:55 PM EST
There may be a lot more riding on Theranos getting a clean bill of health from regulators than the survival of the Palo Alto blood-testing startup itself...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.